Dublin, Oct. 08, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/6xs47x/the_world_market) has announced the addition of the "The World Market for Cancer Diagnostics, 6th Edition" report to their offering.
The World Market for Cancer Diagnostics, 6th Editionprovides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity assessment.
This report is written from the point of view of diagnostic modalities for the detection and management of cancer and in particular solid tumors. The technology to detect cancers of the blood - lymphomas, myelomas and leukemia - is mature and well established.
The routine complete blood count screens for blood cell abnormalities and is followed by bone marrow analysis and flow cytometric studies of the blood cell surface markers. These to arrive at a more specific diagnosis. As such this report does not discuss area of hematological cancer diagnosis in great detail.
This latest report contains detailed market data on the following IVD segments for their use in cancer diagnostics:
- IVD Market for Cancer Tests
- Service Test Market
- Next-Generation Sequencing Technologies
- Tissue Function Tests
- PSA, CEA and Other Immunoassays
- Flow Cytometry
- Pap and HPV Testing
- FOB, and Other Rapid Tests
- Molecular Oncology Assays
- Tissue Microrrays
- Methylated DNA
- In situ hybridization (ISH)
- Immunohistochemistry (IHC)
- Circulating Tumor Cells
- Companion Testing, CDX Products and Deals
Key Topics Covered:
One: Executive Summary
Two: Introduction
Three: Technologies Used In Cancer Diagnostics
Four: Cancer Diagnostics - Applications
Five: Cancer Diagnostic Markets
Six: Deals - Cancer Diagnostics
Seven: Cancer Diagnostics - Market Drivers And Challenges
Eight: In Vitro Cancer Diagnostics Market Analysis
Nine: Company Profiles: Cancer Diagnostic Companies
For more information visit http://www.researchandmarkets.com/research/6xs47x/the_world_market